Westfield National Insurance Company v. Quest Pharmaceuticals, Inc.
Westfield National Insurance Company |
Quest Pharmaceuticals, Inc. |
5:2019cv00083 |
June 11, 2019 |
US District Court for the Western District of Kentucky |
Thomas B Russell |
Insurance |
28 U.S.C. ยง 2201 |
Plaintiff |
Docket Report
This docket was last retrieved on October 1, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 9 ORDER signed by Senior Judge Thomas B. Russell on 7/29/2019. Granting #7 Motion to Strike and Substitute. cc: Counsel(KJA) |
Filing 8 TEXT ORDER by Senior Judge Thomas B. Russell on 7/29/2019. IT IS ORDERED:1. Counsel who will represent the parties at trial and who have full authority to enter stipulations, to make admissions, and to bind the parties with respect to dates agreed upon or ordered shall be available for a TELEPHONIC SCHEDULING CONFERENCE ON AUGUST 15, 2019 at 10:15 a.m. CENTRAL TIME. The Court will place the call to counsel.2. Pursuant to Rule 26(f) Fed.R.Civ.P. counsel shall discuss and establish a discovery plan which shall be submitted to the Court at the scheduling conference either orally during the telephonic conference or in writing. Counsel are directed to make the mandatory disclosures required by Rule 26(a)(l) Fed.R.Civ.P. by said conference date.3. At the Rule 16 telephonic scheduling conference dates will be fixed for the following, as appropriate to the case: a) Joinder of additional parties and amendments to pleadings. b) Disclosure of deadlines for experts. c) Discovery scope, limits and completion. d) Filing of dispositive motions. e) Exchange of exhibits and final witness lists. f) Conferences before trial, including a final pretrial conference. g) Trial. This Notice of Electronic Filing is the Official ORDER for this entry. No document is attached.cc:counsel (KPH) |
Filing 7 MOTION to Strike and Substitute #6 Corporate Disclosure Statement. Document or Part to be Stricken and/or Substituted: Corporate Disclosure Statement #6 by Defendant Quest Pharmaceuticals, Inc. (Attachments: #1 Exhibit Rule 7.1 Corp Disc. Stmt., #2 Proposed Order Proposed Order) (Polczynski, Ryan) |
Filing 6 Corporate Disclosure Statement by Quest Pharmaceuticals, Inc.. (Polczynski, Ryan) (Main Document 6 replaced on 7/30/2019) (KJA). |
Filing 5 ANSWER to #1 Complaint by Quest Pharmaceuticals, Inc.. (Polczynski, Ryan) |
Filing 4 SUMMONS Returned Executed by Westfield National Insurance Company. Quest Pharmaceuticals, Inc. served on 6/16/2019, answer due 7/8/2019. (Walters, John) |
Filing 3 Summons Issued as to Quest Pharmaceuticals, Inc. Counsel for Plaintiff is responsible for printing and serving the attached issued summons(es). (MNM) |
Filing 2 Case Assignment (Random Selection): Case Assigned to Senior Judge Thomas B. Russell. (MNM) |
Filing 1 COMPLAINT against Quest Pharmaceuticals, Inc. Filing fee $400, receipt number 0644-2882287, filed by Westfield National Insurance Company. (Attachments: #1 Cover Sheet, #2 Summons Tendered) (MNM) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Kentucky Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.